Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Orion and Novartis agree on the distribution of entacapone

Aug. 31, 1998

Results of phase II study support efficacy of (S)-fluoxetine as a treatment for migraine

Aug. 31, 1998

News from the ACS: Lilly investigates antioxidants for treating neuronal injury

Aug. 28, 1998

News from the ACS: Roche synthesizes selective 5-HT2C antagonists

Aug. 28, 1998

Schwarz, Discovery Therapeutics collaborate on transdermal treatment for Parkinson's disease

Aug. 27, 1998

Pierre Fabre describes antidepressant compounds with a dual mechanism of action

Aug. 27, 1998

Algos completes full NDA filing for MorphiDex

Aug. 27, 1998

Adding SIB-1508Y to antiparkinsonian therapy allows for reduction in dose of L-dopa

Aug. 27, 1998

SSRI produces significant improvements in patients with social phobia

Aug. 26, 1998

Parke-Davis synthesizes potent and selective D4 ligands with antipsychotic potential

Aug. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.